Cryotech Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 21-12-2024
- Paid Up Capital ₹ 30.00 K
as on 21-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
About Cryotech Pharma
The Corporate was formerly known as Cryotech Phrama Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 30.00 K , as per Ministry of Corporate Affairs (MCA) records.
Salim Hameed, Lalu Joseph, Sergei Afanasev, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24299KL2020PTC063179
- Company No.
063179
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cryotech Pharma?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalu Joseph  | Director | 24-Jul-2020 | Current |
Sergei Afanasev  | Director | 05-May-2022 | Current |
| Salim Hameed | Director | 24-Jul-2020 | Current |
| Jaya Nair | Additional Director | 28-Oct-2021 | Current |
| Samras Mayimi | Additional Director | 22-Jun-2021 | Current |
| Reghunathan Pillai | Director | 24-Jul-2020 | Current |
Financial Performance of Cryotech Pharma.
Cryotech Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cryotech Pharma?
In 2021, Cryotech Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Restart Energy Automobile Private LimitedActive 5 years 9 monthsSamras Mayimi and Reghunathan Pillai are mutual person
- Nrg Corporations Private LimitedActive 1 year 3 months
Samras Mayimi and Reghunathan Pillai are mutual person
- Plasmatron Global Private LimitedActive 4 months 13 days
Samras Mayimi and Reghunathan Pillai are mutual person
- Eurasian Business Services Private LimitedActive 1 year 11 days
Samras Mayimi and Reghunathan Pillai are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cryotech Pharma?
Unlock and access historical data on people associated with Cryotech Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cryotech Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cryotech Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
